BRYNDIR
Live / Applied — Fourth extension granted (statement of use) (as of 02 Feb 2026)
What this means for you
Not registered yet, but its 31 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97866864
- Mark type
- Stylized text
- Filed
- 31 Mar 2023
- Published for opposition
- 30 Jan 2024
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
Prosecution history
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 4 GRANTED
- 02 Feb 2026 — SOU EXTENSION 4 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2025 — SOU EXTENSION 3 GRANTED
- 01 Aug 2025 — SOU EXTENSION 3 FILED
- 01 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jan 2025 — SOU EXTENSION 2 GRANTED
- 31 Jan 2025 — SOU EXTENSION 2 FILED
- 31 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2024 — SOU EXTENSION 1 GRANTED
- 26 Jul 2024 — SOU EXTENSION 1 FILED